Double scan strategy could sharpen tumor treatment decisions
NCT ID NCT04804371
First seen Apr 06, 2026 · Last updated May 22, 2026 · Updated 6 times
Summary
This study looks at whether adding a second type of PET scan (FDG) to the standard scan (DOTATATE) gives doctors more information about neuroendocrine tumors. About 40 adults with grade 2 or 3 gastroenteropancreatic neuroendocrine tumors will get both scans. The goal is to see if the extra scan changes how doctors plan treatment and to learn more about tumor behavior.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROENDOCRINE TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.